Search research articles
Contact Us
Filters
Showing results (211-220 of 246) with videos related to
Page
of 25
Sort By:
Obesity Reviews : an Official Journal of the International Association for the Study of Obesity
|
August 19, 2024
Community-based diet and obesity-related policy, system, and environmental interventions for obesity prevention during the first 1000 days: A scoping review
Chelsea L Kracht, Cody D Neshteruk, Kameron J Moding, et al.
The Journal of Biological Chemistry
|
April 6, 2006
Sp1 is up-regulated in cellular and transgenic models of Huntington disease, and its reduction is neuroprotective
Zhihua Qiu, Fran Norflus, Bhupinder Singh, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
September 15, 1997
Mechanisms of reduced striatal NMDA excitotoxicity in type I nitric oxide synthase knock-out mice
C Ayata, G Ayata, H Hara, et al.
The Journal of Biological Chemistry
|
February 26, 2009
SCAMP5 links endoplasmic reticulum stress to the accumulation of expanded polyglutamine protein aggregates via endocytosis inhibition
Jee-Yeon Noh, Huikyong Lee, Sungmin Song, et al.
Cell Reports
|
December 4, 2012
The sirtuin 2 inhibitor AK-7 is neuroprotective in Huntington's disease mouse models
Vanita Chopra, Luisa Quinti, Jinho Kim, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
October 14, 2011
The melatonin MT1 receptor axis modulates mutant Huntingtin-mediated toxicity
Xin Wang, Ana Sirianni, Zhijuan Pei, et al.
Biochimica Et Biophysica Acta
|
May 13, 2010
Reduced creatine kinase as a central and peripheral biomarker in Huntington's disease
Jinho Kim, Daniel J Amante, Jennifer P Moody, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
February 9, 2013
MAP kinase phosphatase 1 (MKP-1/DUSP1) is neuroprotective in Huntington's disease via additive effects of JNK and p38 inhibition
David M Taylor, Roger Moser, Etienne Régulier, et al.
Amyotrophic Lateral Sclerosis : Official Publication of the World Federation of Neurology Research Group on Motor Neuron Diseases
|
June 23, 2010
Uridine ameliorates the pathological phenotype in transgenic G93A-ALS mice
Daniel J Amante, Jinho Kim, Samantha T Carreiro, et al.
Neurobiology of Disease
|
March 30, 2013
Melatonin inhibits the caspase-1/cytochrome c/caspase-3 cell death pathway, inhibits MT1 receptor loss and delays disease progression in a mouse model of amyotrophic lateral sclerosis
Yi Zhang, Anna Cook, Jinho Kim, et al.
Page
of 25
Search research articles
Search
Showing results (211-220 of 246) with videos related to
Sort By:
Page
of 25
Obesity Reviews : an Official Journal of the International Association for the Study of Obesity
|
August 19, 2024
Community-based diet and obesity-related policy, system, and environmental interventions for obesity prevention during the first 1000 days: A scoping review
Chelsea L Kracht, Cody D Neshteruk, Kameron J Moding, et al.
The Journal of Biological Chemistry
|
April 6, 2006
Sp1 is up-regulated in cellular and transgenic models of Huntington disease, and its reduction is neuroprotective
Zhihua Qiu, Fran Norflus, Bhupinder Singh, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
September 15, 1997
Mechanisms of reduced striatal NMDA excitotoxicity in type I nitric oxide synthase knock-out mice
C Ayata, G Ayata, H Hara, et al.
The Journal of Biological Chemistry
|
February 26, 2009
SCAMP5 links endoplasmic reticulum stress to the accumulation of expanded polyglutamine protein aggregates via endocytosis inhibition
Jee-Yeon Noh, Huikyong Lee, Sungmin Song, et al.
Cell Reports
|
December 4, 2012
The sirtuin 2 inhibitor AK-7 is neuroprotective in Huntington's disease mouse models
Vanita Chopra, Luisa Quinti, Jinho Kim, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
October 14, 2011
The melatonin MT1 receptor axis modulates mutant Huntingtin-mediated toxicity
Xin Wang, Ana Sirianni, Zhijuan Pei, et al.
Biochimica Et Biophysica Acta
|
May 13, 2010
Reduced creatine kinase as a central and peripheral biomarker in Huntington's disease
Jinho Kim, Daniel J Amante, Jennifer P Moody, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
February 9, 2013
MAP kinase phosphatase 1 (MKP-1/DUSP1) is neuroprotective in Huntington's disease via additive effects of JNK and p38 inhibition
David M Taylor, Roger Moser, Etienne Régulier, et al.
Amyotrophic Lateral Sclerosis : Official Publication of the World Federation of Neurology Research Group on Motor Neuron Diseases
|
June 23, 2010
Uridine ameliorates the pathological phenotype in transgenic G93A-ALS mice
Daniel J Amante, Jinho Kim, Samantha T Carreiro, et al.
Neurobiology of Disease
|
March 30, 2013
Melatonin inhibits the caspase-1/cytochrome c/caspase-3 cell death pathway, inhibits MT1 receptor loss and delays disease progression in a mouse model of amyotrophic lateral sclerosis
Yi Zhang, Anna Cook, Jinho Kim, et al.
Page
of 25